The DOI matches its Crossref record; 633 of the 633 references it cites were found in a registry or an index.
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Open accessAbstract
Autoimmune disorders are characterized by aberrant T cell and B cell reactivity to the body’s own components, resulting in tissue destruction and organ dysfunction. Autoimmune diseases affect a wide range of people in many parts of the world and have become one of the major concerns in public health. In recent years, there have been substantial progress in our understanding of the epidemiology, risk factors, pathogenesis and mechanisms of autoimmune diseases. Current approved therapeutic interventions for autoimmune diseases are mainly non-specific immunomodulators and may cause broad immunosuppression that leads to serious adverse effects. To overcome the limitations of immunosuppressive drugs in treating autoimmune diseases, precise and target-specific strategies are urgently needed. To date, significant advances have been made in our understanding of the mechanisms of immune tolerance, offering a new avenue for developing antigen-specific immunotherapies for autoimmune diseases. These antigen-specific approaches have shown great potential in various preclinical animal models and recently been evaluated in clinical trials. This review describes the common epidemiology, clinical manifestation and mechanisms of autoimmune diseases, with a focus on typical autoimmune diseases including multiple sclerosis, type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus, and sjögren’s syndrome. We discuss the current therapeutics developed in this field, highlight the recent advances in the use of nanomaterials and mRNA vaccine techniques to induce antigen-specific immune tolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 633
Intestinal CD103+ dendritic cells: master regulators of tolerance?
Scott, C. L., Aumeunier, A. M., & Mowat, A. M. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.003 · Cited by 321
Alexander, T., Thiel, A., Rosen, O., Massenkeil, G., Sattler, A., Kohler, S., Mei, H., Radtke, H., Gromnica-Ihle, E., Burmester, G.-R., et al. (2009) · Blood · doi:10.1182/blood-2008-07-168286 · Cited by 316
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
Bell, G. M., Anderson, A. E., Diboll, J., Reece, R., Eltherington, O., Harry, R. A., Fouweather, T., MacDonald, C., Chadwick, T., McColl, E., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208456 · Cited by 315
Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells
Tsai, S., Shameli, A., Yamanouchi, J., Clemente-Casares, X., Wang, J., Serra, P., Yang, Y., Medarova, Z., Moore, A., & Santamaria, P. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.015 · Cited by 309
SnapShot: Extracellular Vesicles
Cocozza, F., Grisard, E., Martin-Jaular, L., Mathieu, M., & Théry, C. (2020) · Cell · doi:10.1016/j.cell.2020.04.054 · Cited by 307
In vivo assessment of safety of microneedle arrays in human skin
Bal, S. M., Caussin, J., Pavel, S., & Bouwstra, J. A. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.06.016 · Cited by 303
Coit, P., Jeffries, M., Altorok, N., Dozmorov, M. G., Koelsch, K. A., Wren, J. D., Merrill, J. T., McCune, W. J., & Sawalha, A. H. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.04.003 · Cited by 303
Yeste, A., Nadeau, M., Burns, E. J., Weiner, H. L., & Quintana, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120611109 · Cited by 302
Rizzo, J. D., Wingard, J. R., Tichelli, A., Lee, S. J., Van Lint, M. T., Burns, L. J., Davies, S. M., Ferrara, J. L. M., & Socié, G. (2006) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.09.012 · Cited by 302
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
Skyler, J. S., Cefalu, W. T., Kourides, I. A., Landschulz, W. H., Balagtas, C. C., Cheng, S.-L., & Gelfand, R. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03638-2 · Cited by 301
Hunter, Z., McCarthy, D. P., Yap, W. T., Harp, C. T., Getts, D. R., Shea, L. D., & Miller, S. D. (2014) · ACS Nano · doi:10.1021/nn405033r · Cited by 301
Daniels, T. E., Cox, D., Shiboski, C. H., Schiødt, M., Wu, A., Lanfranchi, H., Umehara, H., Zhao, Y., Challacombe, S., Lam, M. Y., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30381 · Cited by 299
Granzyme K + CD8 T cells form a core population in inflamed human tissue
Jonsson, A. H., Zhang, F., Dunlap, G., Gomez-Rivas, E., Watts, G. F. M., Faust, H. J., Rupani, K. V., Mears, J. R., Meednu, N., Wang, R., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo0686 · Cited by 298
CTLA-4: From mechanism to autoimmune therapy
Hosseini, A., Gharibi, T., Marofi, F., Babaloo, Z., & Baradaran, B. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106221 · Cited by 297
Inducing immune tolerance with dendritic cell-targeting nanomedicines
Cifuentes-Rius, A., Desai, A., Yuen, D., Johnston, A. P. R., & Voelcker, N. H. (2021) · Nature Nanotechnology · doi:10.1038/s41565-020-00810-2 · Cited by 297
ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2
Weber, J. P., Fuhrmann, F., Feist, R. K., Lahmann, A., Al Baz, M. S., Gentz, L.-J., Vu Van, D., Mages, H. W., Haftmann, C., Riedel, R., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141432 · Cited by 295
Gordon, K. B., Foley, P., Krueger, J. G., Pinter, A., Reich, K., Vender, R., Vanvoorden, V., Madden, C., White, K., Cioffi, C., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00126-4 · Cited by 295
The Mechanisms of T Cell Selection in the Thymus
Takaba, H., & Takayanagi, H. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.07.010 · Cited by 292
Bispecific antibodies and their applications
Fan, G., Wang, Z., Hao, M., & Li, J. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0227-0 · Cited by 288
Self-citationMultiple Sclerosis: Immunopathology and Treatment Update
Dargahi, N., Katsara, M., Tselios, T., Androutsou, M.-E., De Courten, M., Matsoukas, J., & Apostolopoulos, V. (2017) · Brain Sciences · doi:10.3390/brainsci7070078 · Cited by 285
An Enigmatic Tail of CD28 Signaling
Boomer, J. S., & Green, J. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002436 · Cited by 283 · cited 1×
“51,52 61 Targeting CTLA4 drugs have been applied in clinical trials in psoriasis and juvenile idiopathic arthritis.”
BackgroundRNAi-based drug design: considerations and future directions
Tang, Q., & Khvorova, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00912-9 · Cited by 282
Lutterotti, A., Yousef, S., Sputtek, A., Stürner, K. H., Stellmann, J.-P., Breiden, P., Reinhardt, S., Schulze, C., Bester, M., Heesen, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006168 · Cited by 281
Mechanisms of T Cell Development and Transformation
Koch, U., & Radtke, F. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154008 · Cited by 281
Clinical Applications of Diabetes Antibody Testing
Bingley, P. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1365 · Cited by 278
OX40, OX40L and Autoimmunity: a Comprehensive Review
Webb, G. J., Hirschfield, G. M., & Lane, P. J. L. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8498-3 · Cited by 277
Walker, L. S. K., Gulbranson-Judge, A., Flynn, S., Brocker, T., Raykundalia, C., Goodall, M., Förster, R., Lipp, M., & Lane, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.8.1115 · Cited by 276
Metzler, B., & Wraith, D. C. (1993) · International Immunology · doi:10.1093/intimm/5.9.1159 · Cited by 275
Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint
Tang, T., Cheng, X., Truong, B., Sun, L., Yang, X., & Wang, H. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107709 · Cited by 271
Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity
Schnell, A., Huang, L., Singer, M., Singaraju, A., Barilla, R. M., Regan, B. M. L., Bollhagen, A., Thakore, P. I., Dionne, D., Delorey, T. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.018 · Cited by 268
HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis
Wang, J., Jelcic, I., Mühlenbruch, L., Haunerdinger, V., Toussaint, N. C., Zhao, Y., Cruciani, C., Faigle, W., Naghavian, R., Foege, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.054 · Cited by 268
Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey
ElTanbouly, M. A., & Noelle, R. J. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00454-2 · Cited by 265
RNA Interference Mechanisms and Applications in Plant Pathology
Rosa, C., Kuo, Y.-W., Wuriyanghan, H., & Falk, B. W. (2018) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-080417-050044 · Cited by 264
Obesity and Multiple Sclerosis: A Mendelian Randomization Study
Mokry, L. E., Ross, S., Timpson, N. J., Sawcer, S., Davey Smith, G., & Richards, J. B. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002053 · Cited by 263
Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity
Fu, Y., Lin, Q., Zhang, Z., & Zhang, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.010 · Cited by 260
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
Waheed, S., Li, Z., Zhang, F., Chiarini, A., Armato, U., & Wu, J. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01605-4 · Cited by 259
Reynisdottir, G., Karimi, R., Joshua, V., Olsen, H., Hensvold, A. H., Harju, A., Engström, M., Grunewald, J., Nyren, S., Eklund, A., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38201 · Cited by 259
Boks, M. A., Kager-Groenland, J. R., Haasjes, M. S. P., Zwaginga, J. J., van Ham, S. M., & ten Brinke, A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2011.11.011 · Cited by 258
Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data
Eshaghi, A., Young, A. L., Wijeratne, P. A., Prados, F., Arnold, D. L., Narayanan, S., Guttmann, C. R. G., Barkhof, F., Alexander, D. C., Thompson, A. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22265-2 · Cited by 257
Bimekizumab versus Adalimumab in Plaque Psoriasis
Warren, R. B., Blauvelt, A., Bagel, J., Papp, K. A., Yamauchi, P., Armstrong, A., Langley, R. G., Vanvoorden, V., De Cuyper, D., Cioffi, C., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102388 · Cited by 252
CD28 is required for germinal center formation
Ferguson, S. E., Han, S., Kelsoe, G., & Thompson, C. B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4576 · Cited by 248
Gaur, A., Wiers, B., Liu, A., Rothbard, J., & Fathman, C. G. (1992) · Science · doi:10.1126/science.1279812 · Cited by 247
ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy
Faraco, J., Lin, L., Kornum, B. R., Kenny, E. E., Trynka, G., Einen, M., Rico, T. J., Lichtner, P., Dauvilliers, Y., Arnulf, I., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003270 · Cited by 245
Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis
Klareskog, L., Malmström, V., Lundberg, K., Padyukov, L., & Alfredsson, L. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.014 · Cited by 244
T cells and the skin: from protective immunity to inflammatory skin disorders
Ho, A. W., & Kupper, T. S. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0162-3 · Cited by 241
Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase
Gigoux, M., Shang, J., Pak, Y., Xu, M., Choe, J., Mak, T. W., & Suh, W.-K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911573106 · Cited by 241
Webb, L. M. C., Walmsley, M. J., & Feldmann, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261008 · Cited by 239
Kishikawa, T., Maeda, Y., Nii, T., Motooka, D., Matsumoto, Y., Matsushita, M., Matsuoka, H., Yoshimura, M., Kawada, S., Teshigawara, S., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215743 · Cited by 238
Current understanding of CTLA-4: from mechanism to autoimmune diseases
Hossen, M. M., Ma, Y., Yin, Z., Xia, Y., Du, J., Huang, J. Y., Huang, J. J., Zou, L., Ye, Z., & Huang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1198365 · Cited by 238
Li, Y., Zhang, K., Chen, H., Sun, F., Xu, J., Wu, Z., Li, P., Zhang, L., Du, Y., Luan, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2779 · Cited by 237
Self-citationMavragani, C. P., & Moutsopoulos, H. M. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104728 · Cited by 237
The molecular basis of TCR germline bias for MHC is surprisingly simple
Christopher Garcia, K., Adams, J. J., Feng, D., & Ely, L. K. (2009) · Nature Immunology · doi:10.1038/ni.f.219 · Cited by 235
Burmester, G.-R., Kivitz, A. J., Kupper, H., Arulmani, U., Florentinus, S., Goss, S. L., Rathmann, S. S., & Fleischmann, R. M. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204769 · Cited by 234
Zaric, M., Lyubomska, O., Touzelet, O., Poux, C., Al-Zahrani, S., Fay, F., Wallace, L., Terhorst, D., Malissen, B., Henri, S., et al. (2013) · ACS Nano · doi:10.1021/nn304235j · Cited by 233
Lu, B., Hiraki, L. T., Sparks, J. A., Malspeis, S., Chen, C.-Y., Awosogba, J. A., Arkema, E. V., Costenbader, K. H., & Karlson, E. W. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205459 · Cited by 232
Autoantibodies Present Before Symptom Onset in Primary Sjögren Syndrome
Jonsson, R. (2013) · JAMA · doi:10.1001/jama.2013.278448 · Cited by 230
Antigen-specific therapeutic approaches for autoimmunity
Serra, P., & Santamaria, P. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0015-4 · Cited by 228
Targeting co-stimulatory molecules in autoimmune disease
Edner, N. M., Carlesso, G., Rush, J. S., & Walker, L. S. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0081-9 · Cited by 228
Immunogenetics of type 1 diabetes: a comprehensive review
Noble, J. A. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.014 · Cited by 227
PTPN22: the archetypal non-HLA autoimmunity gene
Stanford, S. M., & Bottini, N. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.109 · Cited by 227
Immunogenetics of systemic lupus erythematosus: A comprehensive review
Ghodke-Puranik, Y., & Niewold, T. B. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.004 · Cited by 225
Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases
Meredith, M. E., Salameh, T. S., & Banks, W. A. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9719-7 · Cited by 225
Microneedles for painless transdermal immunotherapeutic applications
Amani, H., Shahbazi, M.-A., D'Amico, C., Fontana, F., Abbaszadeh, S., & Santos, H. A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.019 · Cited by 223
Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale
Paramasivam, P., Franke, C., Stöter, M., Höijer, A., Bartesaghi, S., Sabirsh, A., Lindfors, L., Arteta, M. Y., Dahlén, A., Bak, A., et al. (2022) · Journal of Cell Biology · doi:10.1083/jcb.202110137 · Cited by 223
Graham, D. S. C., Graham, R. R., Manku, H., Wong, A. K., Whittaker, J. C., Gaffney, P. M., Moser, K. L., Rioux, J. D., Altshuler, D., Behrens, T. W., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.47 · Cited by 222
Fleischmann, R. M., Bliddal, H., Blanco, F. J., Schnitzer, T. J., Peterfy, C., Chen, S., Wang, L., Feng, S., Conaghan, P. G., Berenbaum, F., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40840 · Cited by 222
The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes
Dong, S., Hiam-Galvez, K. J., Mowery, C. T., Herold, K. C., Gitelman, S. E., Esensten, J. H., Liu, W., Lares, A. P., Leinbach, A. S., Lee, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.147474 · Cited by 222
Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
Charabati, M., Wheeler, M. A., Weiner, H. L., & Quintana, F. J. (2023) · Cell · doi:10.1016/j.cell.2023.03.008 · Cited by 222
Tenspolde, M., Zimmermann, K., Weber, L. C., Hapke, M., Lieber, M., Dywicki, J., Frenzel, A., Hust, M., Galla, M., Buitrago-Molina, L. E., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.05.017 · Cited by 221
Guttman-Yassky, E., Pavel, A. B., Zhou, L., Estrada, Y. D., Zhang, N., Xu, H., Peng, X., Wen, H.-C., Govas, P., Gudi, G., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.11.053 · Cited by 220
Liu, J., Liu, Z., Pang, Y., & Zhou, H. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01343-7 · Cited by 219
Parks, C. G., Cooper, G. S., Nylander‐French, L. A., Sanderson, W. T., Dement, J. M., Cohen, P. L., Dooley, M. A., Treadwell, E. L., St.Clair, E. W., Gilkeson, G. S., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10368 · Cited by 218
Saccardi, R., Kozak, T., Bocelli-Tyndall, C., Fassas, A., Kazis, A., Havrdova, E., Carreras, E., Saiz, A., Löwenberg, B., te Boekhorst, P. A., et al. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506071301 · Cited by 218
Chang, T. T., Jabs, C., Sobel, R. A., Kuchroo, V. K., & Sharpe, A. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.733 · Cited by 215
Inflammatory markers in systemic lupus erythematosus
Aringer, M. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102374 · Cited by 215
Xie, J., Liu, L., Mladkova, N., Li, Y., Ren, H., Wang, W., Cui, Z., Lin, L., Hu, X., Yu, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15383-w · Cited by 215
Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group, Krischer, J. P., Schatz, D. A., Bundy, B., Skyler, J. S., & Greenbaum, C. J. (2017) · JAMA · doi:10.1001/jama.2017.17070 · Cited by 214
Atisha‐Fregoso, Y., Malkiel, S., Harris, K. M., Byron, M., Ding, L., Kanaparthi, S., Barry, W. T., Gao, W., Ryker, K., Tosta, P., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41466 · Cited by 214
Wang, Q., Jiang, H., Li, Y., Chen, W., Li, H., Peng, K., Zhang, Z., & Sun, X. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.008 · Cited by 213
Alhadj Ali, M., Liu, Y.-F., Arif, S., Tatovic, D., Shariff, H., Gibson, V. B., Yusuf, N., Baptista, R., Eichmann, M., Petrov, N., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7779 · Cited by 212
Karin, N., Mitchell, D. J., Brocke, S., Ling, N., & Steinman, L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2227 · Cited by 211
Biological drug and drug delivery-mediated immunotherapy
Xiao, Q., Li, X., Li, Y., Wu, Z., Xu, C., Chen, Z., & He, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.018 · Cited by 211
Rogers, M. A. M., Kim, C., Banerjee, T., & Lee, J. M. (2017) · BMC Medicine · doi:10.1186/s12916-017-0958-6 · Cited by 208
RNA interference in the era of nucleic acid therapeutics
Jadhav, V., Vaishnaw, A., Fitzgerald, K., & Maier, M. A. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-02105-y · Cited by 207
Curing CNS autoimmune disease with myelin‐reactive Foxp3+ Treg
Stephens, L. A., Malpass, K. H., & Anderton, S. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200839073 · Cited by 206
Simpson, S., Wang, W., Otáhal, P., Blizzard, L., van der Mei, I. A. F., & Taylor, B. V. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320189 · Cited by 205
Jayne, D., Rovin, B., Mysler, E. F., Furie, R. A., Houssiau, F. A., Trasieva, T., Knagenhjelm, J., Schwetje, E., Chia, Y. L., Tummala, R., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221478 · Cited by 205
Chow, C. K., Ramasundarahettige, C., Hu, W., AlHabib, K. F., Avezum, A., Cheng, X., Chifamba, J., Dagenais, G., Dans, A., Egbujie, B. A., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30233-x · Cited by 203
Burt, R. K., Balabanov, R., Han, X., Sharrack, B., Morgan, A., Quigley, K., Yaung, K., Helenowski, I. B., Jovanovic, B., Spahovic, D., et al. (2015) · JAMA · doi:10.1001/jama.2014.17986 · Cited by 200
Kersh, G. J., & Allen, P. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1259 · Cited by 199
Tolerogenic nanoparticles inhibit T cell–mediated autoimmunity through SOCS2
Yeste, A., Takenaka, M. C., Mascanfroni, I. D., Nadeau, M., Kenison, J. E., Patel, B., Tukpah, A.-M., Babon, J. A. B., DeNicola, M., Kent, S. C., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aad0612 · Cited by 199
Insulin as an autoantigen in NOD/human diabetes
Zhang, L., Nakayama, M., & Eisenbarth, G. S. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.11.005 · Cited by 197
Wang, J., Shan, Y., Jiang, Z., Feng, J., Li, C., Ma, L., & Jiang, Y. (2013) · Clinical and Experimental Immunology · doi:10.1111/cei.12162 · Cited by 196
Effects of interleukin-2 in immunostimulation and immunosuppression
Pol, J. G., Caudana, P., Paillet, J., Piaggio, E., & Kroemer, G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191247 · Cited by 195
Inflammation-related plasma and CSF biomarkers for multiple sclerosis
Huang, J., Khademi, M., Fugger, L., Lindhe, Ö., Novakova, L., Axelsson, M., Malmeström, C., Constantinescu, C., Lycke, J., Piehl, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912839117 · Cited by 194
RNA Identification of PRIME Cells Predicting Rheumatoid Arthritis Flares
Orange, D. E., Yao, V., Sawicka, K., Fak, J., Frank, M. O., Parveen, S., Blachere, N. E., Hale, C., Zhang, F., Raychaudhuri, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004114 · Cited by 192
Raptopoulou, A. P., Bertsias, G., Makrygiannakis, D., Verginis, P., Kritikos, I., Tzardi, M., Klareskog, L., Catrina, A. I., Sidiropoulos, P., & Boumpas, D. T. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27500 · Cited by 191
Engineering antigens for in situ erythrocyte binding induces T-cell deletion
Kontos, S., Kourtis, I. C., Dane, K. Y., & Hubbell, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216353110 · Cited by 190
DNA vaccines: prime time is now
Gary, E. N., & Weiner, D. B. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.01.006 · Cited by 190
Zubizarreta, I., Flórez-Grau, G., Vila, G., Cabezón, R., España, C., Andorra, M., Saiz, A., Llufriu, S., Sepulveda, M., Sola-Valls, N., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820039116 · Cited by 189
T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins
Roep, B. O., Arden, S. D., de vries, R. R. P., & Hutton, J. C. (1990) · Nature · doi:10.1038/345632a0 · Cited by 185 · cited 1×
“147 These immune cells will lose the immune regulation function gradually with the T1D development.”
BackgroundCarambia, A., Freund, B., Schwinge, D., Bruns, O. T., Salmen, S. C., Ittrich, H., Reimer, R., Heine, M., Huber, S., Waurisch, C., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.006 · Cited by 181
Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
Garren, H., Robinson, W. H., Krasulová, E., Havrdová, E., Nadj, C., Selmaj, K., Losy, J., Nadj, I., Radue, E., Kidd, B. A., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21370 · Cited by 181
Karikó, K., & Weissman, D. (2007) · PubMed · Cited by 179
Tengn�r, P., Halse, A.-K., Haga, H.-J., Jonsson, R., & Wahren-Herlenius, M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2238::aid-art20>3.0.co;2-v · Cited by 178
Tailor made: the art of therapeutic mRNA design
Metkar, M., Pepin, C. S., & Moore, M. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00827-x · Cited by 178
Do DNA Vaccines Induce Autoimmune Disease?
Mor, G., Singla, M., Steinberg, A. D., Hoffman, S. L., Okuda, K., & Klinman, D. M. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.3-293 · Cited by 177
Therapeutic induction of antigen-specific immune tolerance
Kenison, J. E., Stevens, N. A., & Quintana, F. J. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00970-x · Cited by 177
Ramos-Casals, M., Brito-Zerón, P., Kostov, B., Sisó-Almirall, A., Bosch, X., Buss, D., Trilla, A., Stone, J. H., Khamashta, M. A., & Shoenfeld, Y. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.03.008 · Cited by 176
Haematopoietic stem cell transplantation for autoimmune diseases
Swart, J. F., Delemarre, E. M., van Wijk, F., Boelens, J.-J., Kuball, J., van Laar, J. M., & Wulffraat, N. M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.7 · Cited by 175
Differential diagnosis of suspected multiple sclerosis: an updated consensus approach
Solomon, A. J., Arrambide, G., Brownlee, W. J., Flanagan, E. P., Amato, M. P., Amezcua, L., Banwell, B., Barkhof, F., Corboy, J. R., Correale, J. D., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00148-5 · Cited by 175
Daikeler, T., Labopin, M., Di Gioia, M., Abinun, M., Alexander, T., Miniati, I., Gualandi, F., Fassas, A., Martin, T., Schwarze, C. P., et al. (2011) · Blood · doi:10.1182/blood-2011-02-336156 · Cited by 174
Kloppenburg, M., Peterfy, C., Haugen, I. K., Kroon, F., Chen, S., Wang, L., Liu, W., Levy, G., Fleischmann, R. M., Berenbaum, F., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213336 · Cited by 174
Bone marrow hematopoiesis drives multiple sclerosis progression
Shi, K., Li, H., Chang, T., He, W., Kong, Y., Qi, C., Li, R., Huang, H., Zhu, Z., Zheng, P., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.020 · Cited by 174
Wang, Y.-S., Kumari, M., Chen, G.-H., Hong, M.-H., Yuan, J. P.-Y., Tsai, J.-L., & Wu, H.-C. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00977-5 · Cited by 173
Glatt, S., Jemec, G. B. E., Forman, S., Sayed, C., Schmieder, G., Weisman, J., Rolleri, R., Seegobin, S., Baeten, D., Ionescu, L., et al. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.2905 · Cited by 172
Roep, B. O., Solvason, N., Gottlieb, P. A., Abreu, J. R. F., Harrison, L. C., Eisenbarth, G. S., Yu, L., Leviten, M., Hagopian, W. A., Buse, J. B., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006103 · Cited by 170
How Follicular Dendritic Cells Shape the B-Cell Antigenome
Kranich, J., & Kräutler, N. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00225 · Cited by 169
Antibody therapeutics and immunoregulation in cancer and autoimmune disease
Yasunaga, M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.001 · Cited by 169
Glatiramer acetate: Mechanisms of action in multiple sclerosis
Schrempf, W., & Ziemssen, T. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.02.003 · Cited by 168
Viral infection can induce the production of autoantibodies
Barzilai, O., Ram, M., & Shoenfeld, Y. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282f0ad25 · Cited by 168
Follicular helper T cells may play an important role in the severity of primary Sjögren's syndrome
Szabo, K., Papp, G., Barath, S., Gyimesi, E., Szanto, A., & Zeher, M. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.02.024 · Cited by 168
Gardner, R. M., Nyland, J. F., Silva, I. A., Maria Ventura, A., Maria de Souza, J., & Silbergeld, E. K. (2010) · Environmental Research · doi:10.1016/j.envres.2010.02.001 · Cited by 168
Elinav, E., Adam, N., Waks, T., & Eshhar, Z. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.049 · Cited by 168
Adoptive Treg Cell Therapy in a Patient With Systemic Lupus Erythematosus
Dall'Era, M., Pauli, M. L., Remedios, K., Taravati, K., Sandova, P. M., Putnam, A. L., Lares, A., Haemel, A., Tang, Q., Hellerstein, M., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40737 · Cited by 168
Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery
Herrera, M., Kim, J., Eygeris, Y., Jozic, A., & Sahay, G. (2021) · Biomaterials Science · doi:10.1039/d0bm01947j · Cited by 167
Bar-Or, A., Vollmer, T., Antel, J., Arnold, D. L., Bodner, C. A., Campagnolo, D., Gianettoni, J., Jalili, F., Kachuck, N., Lapierre, Y., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.10.nct70002 · Cited by 166
Peptide–MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices
Singha, S., Shao, K., Yang, Y., Clemente-Casares, X., Solé, P., Clemente, A., Blanco, J., Dai, Q., Song, F., Liu, S. W., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.56 · Cited by 166
Cappellano, G., Woldetsadik, A. D., Orilieri, E., Shivakumar, Y., Rizzi, M., Carniato, F., Gigliotti, C. L., Boggio, E. M., Clemente, N., Comi, C., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.016 · Cited by 165
Pons‐Estel, B. A., Bonfá, E., Soriano, E. R., Cardiel, M. H., Izcovich, A., Popoff, F., Criniti, J. M., Vásquez, G. M., Massardo, L., Duarte, M., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213512 · Cited by 165
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome
Mariette, X., Barone, F., Baldini, C., Bootsma, H., Clark, K. L., Vita, S. D., Gardner, D. H., Henderson, R. B., Herdman, M., Lerang, K., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.163030 · Cited by 164
Smilek, D. E., Wraith, D. C., Hodgkinson, S., Dwivedy, S., Steinman, L., & McDevitt, H. O. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9633 · Cited by 162
Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells
Reincke, S. M., von Wardenburg, N., Homeyer, M. A., Kornau, H., Spagni, G., Li, L. Y., Kreye, J., Sánchez-Sendín, E., Blumenau, S., Stappert, D., et al. (2023) · Cell · doi:10.1016/j.cell.2023.10.001 · Cited by 162
Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain
Ogawa, K., Kato, N., Yoshida, M., Hiu, T., Matsuo, T., Mizukami, S., Omata, D., Suzuki, R., Maruyama, K., Mukai, H., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.042 · Cited by 161
Fitzgerald, K. C., Munger, K. L., Köchert, K., Arnason, B. G. W., Comi, G., Cook, S., Goodin, D. S., Filippi, M., Hartung, H.-P., Jeffery, D. R., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.2742 · Cited by 161
Morand, E. F., Vital, E. M., Petri, M., van Vollenhoven, R., Wallace, D. J., Mosca, M., Furie, R. A., Silk, M. E., Dickson, C. L., Meszaros, G., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02607-1 · Cited by 161
D’Addio, F., Valderrama Vasquez, A., Ben Nasr, M., Franek, E., Zhu, D., Li, L., Ning, G., Snarski, E., & Fiorina, P. (2014) · Diabetes · doi:10.2337/db14-0295 · Cited by 160
Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies
Thorlacius, G. E., Björk, A., & Wahren-Herlenius, M. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00932-6 · Cited by 160
Lee, S. J., Lee, A., Hwang, S. R., Park, J.-S., Jang, J., Huh, M. S., Jo, D.-G., Yoon, S.-Y., Byun, Y., Kim, S. H., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2013.245 · Cited by 159
Pishesha, N., Bilate, A. M. B., Wibowo, M. C., Huang, N.-J., Li, Z., Deshycka, R., Bousbaine, D., Li, H., Patterson, H. C., Dougan, S. K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701746114 · Cited by 159
Shipa, M., Embleton-Thirsk, A., Parvaz, M., Santos, L. R., Muller, P., Chowdhury, K., Isenberg, D. A., Doré, C. J., Gordon, C., Ehrenstein, M. R., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-2078 · Cited by 159
Association Between Cigarette Smoking and Multiple Sclerosis: A Review
Rosso, M., & Chitnis, T. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4271 · Cited by 158
Sex steroids and autoimmune rheumatic diseases: state of the art
Cutolo, M., & Straub, R. H. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0503-4 · Cited by 158
Within-host evolution of a gut pathobiont facilitates liver translocation
Yang, Y., Nguyen, M., Khetrapal, V., Sonnert, N. D., Martin, A. L., Chen, H., Kriegel, M. A., & Palm, N. W. (2022) · Nature · doi:10.1038/s41586-022-04949-x · Cited by 158
Roles of BTLA in Immunity and Immune Disorders
Ning, Z., Liu, K., & Xiong, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654960 · Cited by 157
Michel, M., Terriou, L., Roudot‐Thoraval, F., Hamidou, M. A., Ebbo, M., Guenno, G. L., Galicier, L., Audia, S., Royer, B., Morin, A. S., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24570 · Cited by 157
Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014
Scherlinger, M., Mertz, P., Sagez, F., Meyer, A., Felten, R., Chatelus, E., Javier, R., Sordet, C., Martin, T., Korganow, A., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102531 · Cited by 157
Norman, J. J., Brown, M. R., Raviele, N., Prausnitz, M. R., & Felner, E. I. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12031 · Cited by 153
Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus
Jog, N. R., & James, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.623944 · Cited by 151
Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly
Veerapathran, A., Pidala, J., Beato, F., Yu, X., & Anasetti, C. (2011) · Blood · doi:10.1182/blood-2011-02-337097 · Cited by 147
Östman, J., Lönnberg, G., Arnqvist, H. J., Blohmé, G., Bolinder, J., Schnell, A. E., Eriksson, J. W., Gudbjörnsdottir, S., Sundkvist, G., & Nyström, L. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01896.x · Cited by 147
Warren, K. G., Catz, I., Ferenczi, L. Z., & Krantz, M. J. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01533.x · Cited by 147
Horton, H. M., Chu, S. Y., Ortiz, E., Pong, E., Čemerski, S., Leung, I., Jacob, N., Zalevsky, J., Desjarlais, J. R., Stohl, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003412 · Cited by 147
Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis
Gourh, P., Arnett, F. C., Tan, F. K., Assassi, S., Divecha, D., Paz, G., McNearney, T. A., Draeger, H. T., Reveille, J. D., Mayes, M. D., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.116434 · Cited by 145
Goules, A. V., Tzioufas, A. G., Manousakis, M., Kirou, K. A., Crow, M. K., & Routsias, J. G. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.02.002 · Cited by 144
Isenberg, D. A., Furie, R. A., Jones, N. S., Guibord, P., Galanter, J., Lee, C., McGregor, A. G., Tóth, B. I., Rae, J., Hwang, O., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41811 · Cited by 144
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
Freedman, M. S., Bar‐Or, A., Oger, J. J.-F., Traboulsee, A. L., Patry, D., Young, C. A., Olsson, T. P., Li, D., Hartung, H. ‐., Krantz, M. J., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318233b240 · Cited by 143
Tolerogenic dendritic cells for autoimmune disease and transplantation
Thomson, A. W., & Robbins, P. D. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.099176 · Cited by 142
Han, B., Serra, P., Amrani, A., Yamanouchi, J., Marée, A. F. M., Edelstein‐Keshet, L., & Santamaría, P. (2005) · Nature Medicine · doi:10.1038/nm1250 · Cited by 142
Choreographing Immunity in the Skin Epithelial Barrier
Kobayashi, T., Naik, S., & Nagao, K. (2019) · Immunity · doi:10.1016/j.immuni.2019.02.023 · Cited by 141
Monogenic lupus: Dissecting heterogeneity
Omarjee, O., Picard, C., Frachette, C., Moreews, M., Rieux‐Laucat, F., Soulas-Sprauel, P., Viel, S., Lega, J., Bader‐Meunier, B., Walzer, T., et al. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102361 · Cited by 138
Garren, H., Ruiz, P. J., Watkins, T. A., da Fontoura, P. P., Nguyen, L.-V. T., Estline, E. R., Hirschberg, D. L., & Steinman, L. (2001) · Immunity · doi:10.1016/s1074-7613(01)00171-6 · Cited by 137
Cao, Y., Xie, L., Shi, F., Tang, M., Li, Y., Hu, J., Zhao, L., Zhao, L., Yu, X., Luo, X., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00376-4 · Cited by 137
Khatri, B., Tessneer, K. L., Rasmussen, A., Aghakhanian, F. F., Reksten, T. R., Adler, A., Alevizos, I., Anaya, J., Aqrawi, L. A., Baecklund, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30773-y · Cited by 136
Mancardi, G., Sormani, M. P., Gioia, M. D., Vuolo, L., Gualandi, F., Amato, M. P., Capello, E., Currò, D., Uccelli, A., Bertolotto, A., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511429320 · Cited by 135
Poly(lactic acid)-based particulate systems are promising tools for immune modulation
Peres, C., Matos, A. I., Conniot, J., Sainz, V., Zupančič, E., Silva, J. M., Graça, L., Gaspar, R. S., Préat, V., & Florindo, H. F. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.012 · Cited by 135
van der Heijde, D. M. F. M., Gensler, L. S., Deodhar, A. A., Baraliakos, X., Poddubnyy, D., Kivitz, A., Farmer, M. K., Baeten, D., Goldammer, N., Coarse, J., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-216980 · Cited by 135
Tolerogenic dendritic cells and their applications in transplantation
Li, H., & Shi, B. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.52 · Cited by 132
Aldayel, A. M., O’Mary, H. L., Valdes, S. A., Li, X., Thakkar, S. G., Mustafa, B. E., & Cui, Z. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.035 · Cited by 129
Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity
Wagner, C. A., Roqué, P. J., Mileur, T. R., Liggitt, D., & Goverman, J. M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci132531 · Cited by 127
Cappellano, G., Comi, C., Chiocchetti, A., & Dianzani, U. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010204 · Cited by 126
Kim, Y. C., Zhang, A.-H., Yoon, J., Culp, W. E., Lees, J. R., Wucherpfennig, K. W., & Scott, D. W. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.05.003 · Cited by 125
Hematopoietic Stem Cell Transplantation for Autoimmune Disease
Alexander, T., Greco, R., & Snowden, J. A. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-070119-115617 · Cited by 124
Huibregtse, I. L., Snoeck, V., Creus, A. D., Braat, H., de Jong, E. C., van Deventer, S. J. H., & Rottiers, P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.073 · Cited by 123
Alcohol Consumption and Risk of Incident Rheumatoid Arthritis in Women: A Prospective Study
Lü, B., Solomon, D. H., Costenbader, K. H., & Karlson, E. W. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38634 · Cited by 123
Coit, P., Dozmorov, M. G., Merrill, J. T., McCune, W. J., Maksimowicz‐McKinnon, K., Wren, J. D., & Sawalha, A. H. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39720 · Cited by 123
Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery
Duong, V., Nguyen, T., & Maeng, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010207 · Cited by 123
van der Heijde, D. M. F. M., Deodhar, A. A., Baraliakos, X., Brown, M. A., Dobashi, H., Dougados, M., Elewaut, D. S., Ellis, A. M., Fleurinck, C., Gaffney, K., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223595 · Cited by 123
Xu, X., Wang, X., Liao, Y., Luo, L., Xia, T., & Nel, A. E. (2023) · ACS Nano · doi:10.1021/acsnano.2c12420 · Cited by 123
Duan, W., & Li, H. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0382-x · Cited by 122
Antigen-Specific Suppression of Inflammatory Arthritis Using Liposomes
Capini, C., Jaturanpinyo, M., Chang, H.-I., Mutalik, S., McNally, A., Street, S. E. A., Steptoe, R. J., O’Sullivan, B., Davies, N. M., & Thomas, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802972 · Cited by 121
Notch1 targeting siRNA delivery nanoparticles for rheumatoid arthritis therapy
Kim, M. J., Park, J. S., Lee, S. J., Jang, J., Park, J. S., Back, S. H., Bahn, G., Park, J. H., Kang, Y. M., Kim, S. H., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.025 · Cited by 120
Regué, D. R., Grau‐López, L., Naranjo‐Gómez, M., Ramo-Tello, C. M., Pujol‐Borrell, R., Martínez-Cáceres, E. M., & Borràs, F. E. (2012) · European Journal of Immunology · doi:10.1002/eji.201141835 · Cited by 120
Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes
Campbell‐Thompson, M., Filipp, S. L., Grajo, J. R., Nambam, B., Beegle, R. D., Middlebrooks, E. H., Gurka, M. J., Atkinson, M. A., Schatz, D., & Haller, M. J. (2018) · Diabetes Care · doi:10.2337/dc18-1512 · Cited by 120
Walter, M., Philotheou, A., Bonnici, F., Ziegler, A.-G., Jimenez, R., & on behalf of the NBI-6024 Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0449 · Cited by 119
LaMothe, R. A., Kolte, P. N., Vo, T., Ferrari, J. D., Gelsinger, T. C., Wong, J., Chan, V., Ahmed, S., Srinivasan, A., Deitemeyer, P., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00281 · Cited by 119
DNA immunization to prevent autoimmune diabetes
Coon, B., An, L., Whitton, J. L., & von Herrath, M. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7209 · Cited by 118
Environmental factors in the pathogenesis of primary Sjögren's syndrome
Björk, A., Mofors, J., & Wahren‐Herlenius, M. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13032 · Cited by 118
Zhang, L., Sosinowski, T., Cox, A. R., Cepeda, J. R., Sekhar, N. S., Hartig, S. M., Miao, D., Yu, L., Pietropaolo, M., & Davidson, H. W. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.08.004 · Cited by 117
Zipfel, P. F., Wiech, T., Stea, E. D., & Skerka, C. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019050515 · Cited by 116
Zhang, B., Wang, Y., Yuan, Y., Sun, J., Liu, L., Huang, D., Hu, J., Wang, M., Li, S., Song, W., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217844 · Cited by 116
Chen, K., Fan, N., Huang, H., Jiang, X., Qin, S., Xiao, W., Zheng, Q., Zhang, Y., Duan, X., Qin, Z., et al. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202204692 · Cited by 116
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment
Walczak, A., Siger, M., Ciach, A., Szczepanik, M., & Selmaj, K. W. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3022 · Cited by 115
Pulmonary and Thrombotic Manifestations of Systemic Lupus Erythematosus
Swigris, J. J., Fischer, A., Gilles, J., Meehan, R. T., & Brown, K. K. (2008) · CHEST Journal · doi:10.1378/chest.07-0079 · Cited by 114
Tolerogenic nanoparticles suppress central nervous system inflammation
Kenison, J. E., Jhaveri, A. M., Li, Z., Khadse, N., Tjon, E. C., Tezza, S., Nowakowska, D., Plasencia, A., Stanton, V. P., Sherr, D. H., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016451117 · Cited by 111
Latent, Immunosuppressive Nature of Poly(lactic- co -glycolic acid) Microparticles
Allen, R. P., Bolandparvaz, A., Jeffrey, A., Manickam, V. A., & Lewis, J. S. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00831 · Cited by 110
Allanore, Y., Wung, P. K., Soubrane, C., Espéret, C., Marrache, F., Bejuit, R., Lahmar, A., Khanna, D., & Denton, C. P. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218447 · Cited by 110
Emery, P. E., Bingham, C. O., Burmester, G. R., Bykerk, V. P., Furst, D. E., Xavier Mariette, A., van der Heijde, D. M. F. M., van Vollenhoven, R., Arendt, C. H., Mountian, I., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-209057 · Cited by 109
Casella, G., Rasouli, J., Boehm, A., Zhang, W., Xiao, D., Ishikawa, L. L. W., Thomé, R., Li, X., Hwang, D., Porazzi, P., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aba0599 · Cited by 109
Protective effects of Fc-fused PD-L1 on two different animal models of colitis
Song, M.-Y., Hong, C., Park, S. J., Kim, J.-H., Yang, B., Park, Y., Kim, S. W., Kim, K. S., Lee, J. Y., Lee, S., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307311 · Cited by 108
Metadata
- Authors
- Song, Y., Li, J., & Wu, Y.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-10-04
- Volume
- 9
- Issue
- 1
- Pages
- 263-263
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4403086871
- Cited by
- 259
- References
- 633
- FWCI
- 35.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.